Clin2
NCT07274137Possibly a fitNot yet recruiting

Weight-loss drug study for people with obesity or overweight

Overweight or Obesity

Treatments studied

Part of Hormones & metabolism clinical trials.

This trial tests an investigational weight-loss medication (MDR-001) for people who are overweight or have obesity. Researchers want to see if this drug helps with weight loss and is safe when taken along with diet and exercise.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
738 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have obesity (BMI 28 or higher) OR you are overweight (BMI 24 to below 28) AND have a weight-related health problem like high blood pressure, high cholesterol, fatty liver, sleep apnea, or joint pain.
  • You have not been diagnosed with diabetes (type 1 or 2).
  • You have not used prescription weight-loss drugs in the past 3 months.
  • You do not have a history of serious health issues such as heart disease, stroke, pancreatitis, depression, suicidal thoughts, certain thyroid conditions, or cancer in the last 5 years.
  • Your weight has been stable (no more than 5% change) for the past 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07110766Not yet recruiting· Phase 1
Study of MDR-001 for obesity or overweight people

This trial tests an experimental drug, MDR-001, to see if it is safe and helps with weight loss. It is for Chinese adults who are obese or overweight and have related health problems like pre-diabetes or high blood pressure.

Ch’ang-ch’un, Jilin
NCT06606483Not yet recruiting· Phase 2
Study of MDR-001 in adults with obesity or overweight

This study tests a new medication called MDR-001 for helping people lose weight. It is for adults who are either obese or overweight with related health issues. The goal is to see if the drug is safe and effective for weight loss.

Hefei, Anhui
NCT06778850Recruiting· Phase 1/Phase 2
Study of MDR-001 tablet for overweight or obese adults

This study tests a new tablet called MDR-001 for people who are overweight or obese. Researchers want to see if it is safe and helps with weight loss. You would take the tablet in different doses over several weeks.

Changchun, Jilin
NCT07518589Not yet recruiting· Phase 1
Testing a new weight-management drug in healthy adults

This early-stage trial tests how safe and tolerable CMS-D008, an experimental weight-management medicine, is in healthy adults who are overweight or obese. Researchers will gradually increase the dose to find the right amount and monitor how your body responds.

NCT07437079Recruiting· Phase 1
Testing a new weight-loss medicine in healthy people

This study tests a new medicine (NNC6989-0001) for people who are overweight or have obesity. It checks if the medicine is safe and how the body handles it. If eligible, you would receive the study drug and be monitored closely.

Lenexa, Kansas
NCT07279194Recruiting· Phase 3
Study of HDM1005 for weight loss in Chinese adults without diabetes

This trial tests a new medication, HDM1005, to help people with obesity or overweight who do not have diabetes lose weight. It is for Chinese adults who have a high body mass index (BMI) or a BMI above 24 with weight-related health problems like high blood pressure or fatty liver.

Shanghai

Hear when a new Overweight or Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.